Income and Other Taxes
Pfizer Income and Other Taxes increased by 101.1% to $72.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 52.6%, from $152.00M to $72.00M. Over 4 years (FY 2021 to FY 2025), Income and Other Taxes shows a downward trend with a 24.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
High cash tax payments relative to income tax expense may indicate timing differences or deferred tax settlements, while low payments may suggest tax planning efficiency.
Detailed definition
The total cash outflow related to income taxes and other tax-related obligations during the period. This metric reflects...
Peer comparison
Highly dependent on the geographic mix of earnings and the effective tax rate of the company's operating jurisdictions.
unp_income_and_other_taxes_paidHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.79B | $755.00M | -$4.11B | $354.00M | $2.74B | $1.82B | -$5.46B | $329.00M | $1.70B | $882.00M | -$3.89B | $184.00M | $2.50B | $486.00M | -$4.52B | $152.00M | $3.34B | $178.00M | -$6.48B | $72.00M |
| QoQ Change | — | -57.9% | -644.2% | +108.6% | +675.1% | -33.6% | -400.1% | +106.0% | +415.5% | -48.0% | -540.9% | +104.7% | >999% | -80.6% | <-999% | +103.4% | >999% | -94.7% | <-999% | +101.1% |
| YoY Change | — | — | — | — | +53.0% | +141.2% | -33.0% | -7.1% | -38.2% | -51.6% | +28.8% | -44.1% | +47.5% | -44.9% | -16.1% | -17.4% | +33.5% | -63.4% | -43.4% | -52.6% |
Income and Other Taxes at Other Companies
Frequently Asked Questions
- What is Pfizer's income and other taxes?
- Pfizer (PFE) reported income and other taxes of $72.00M in Q1 2026.
- How has Pfizer's income and other taxes changed year-over-year?
- Pfizer's income and other taxes decreased by 52.6% year-over-year, from $152.00M to $72.00M.
- What is the long-term trend for Pfizer's income and other taxes?
- Over 4 years (2021 to 2025), Pfizer's income and other taxes has grown at a 24.5% compound annual growth rate (CAGR), from -$1.17B to -$2.81B.
- What does income and other taxes mean?
- The total amount of cash paid for taxes.